|
Volumn 10, Issue 6, 2005, Pages 438-440
|
A new therapeutic approach in patients with advanced sarcoma
|
Author keywords
Antiangiogenic; Oral; Proapoptotic; Sarcoma
|
Indexed keywords
CYCLOOXYGENASE 2 INHIBITOR;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;
PIOGLITAZONE;
ROFECOXIB;
TROFOSFAMIDE;
ADULT;
ADVANCED CANCER;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER RADIOTHERAPY;
CANCER RELAPSE;
CANCER SURGERY;
CLINICAL ARTICLE;
DISEASE COURSE;
DRUG EFFICACY;
FEMALE;
HOSPITALIZATION;
HUMAN;
LOW DRUG DOSE;
MAINTENANCE THERAPY;
MALE;
NEPHROTOXICITY;
PILOT STUDY;
PRIORITY JOURNAL;
SARCOMA;
TREATMENT OUTCOME;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
CYCLOPHOSPHAMIDE;
FEMALE;
HUMANS;
LACTONES;
MALE;
MIDDLE AGED;
NEOVASCULARIZATION, PATHOLOGIC;
PALLIATIVE CARE;
PILOT PROJECTS;
SARCOMA;
SOFT TISSUE NEOPLASMS;
SULFONES;
THIAZOLIDINEDIONES;
TREATMENT OUTCOME;
|
EID: 29244477812
PISSN: 13419625
EISSN: None
Source Type: Journal
DOI: 10.1007/s10147-005-0514-9 Document Type: Article |
Times cited : (11)
|
References (6)
|